Virtual Practice in Obesity Management Through Simulated Scenarios

Overview

Provider Statement

This continuing education activity is provided by 

Support Statement

This activity is supported by an educational grant from Lilly.

Activity Description

Obesity is an increasingly prevalent chronic condition associated with substantial risks of morbidity and mortality. It is also a risk factor for some of the leading causes of preventable death, including cardiovascular disease, stroke, type 2 diabetes mellitus, sleep apnea, gallbladder disease, osteoarthritis, and certain types of cancer. With prevalence continuing to escalate, it is predicted that 1 of 2 persons in the United States will have obesity by 2030. Among the groups most at risk for severe obesity are women, Black non-Hispanic adults, and adults with low income. Currently, underdiagnosis and undertreatment of obesity are frequent due to shortcomings in patient evaluation, uncertainty regarding approaches that support adherence to behavioral and lifestyle modifications, and a lack of thorough knowledge concerning the efficacy and safety of pharmacological and surgical interventions. In this virtual patient management simulator, an authentic in-office setting with patient interactions will be presented. This simulation will allow an authentic practice environment in which to implement guidelines and treatment strategies across an array of increasingly challenging clinical presentations. Virtual Practice in Obesity Management Through Simulated Scenarios will demonstrate approaches to managing patients with obesity based on patient needs, comorbidities, recent clinical evidence, and the use of shared decision-making.

Target Audience

The intended audience for this activity is family medicine physicians, internists, and other healthcare professionals involved in the management of patients with overweight and obesity.

Learning Objectives

Upon successful completion of this activity, participants should be better able to:

• Recognize obesity as a chronic but treatable disease and incorporate strategies for the timely diagnosis of the condition.
• Apply approaches to manage obesity based on therapeutic interventions, patient needs, complications/comorbidities, and recent clinical evidence, including long-term management strategies.
• Demonstrate the use of shared decision-making to initiate weight loss conversations and facilitate discussions on evidence-based anti-obesity medications.

Activity Chair

Scott Kahan, MD, MPH, FTOS, DABOM
Director, National Center for Weight and Wellness
Johns Hopkins Bloomberg School of Public Health
Washington, DC

Faculty

Carol H. Wysham, MD, FACP, FACE
Clinical Professor of Medicine
University of Washington School of Medicine
MultiCare Rockwood Clinic Diabetes & Endocrinology Center
Spokane, WA

Planner/Reviewer

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP

Accreditation

In support of improving patient care, Vindico Medical Education is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

Vindico Medical Education designates this enduring material for a maximum of 1.5 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Successful completion of this CE activity, which includes participation in the evaluation component, enables the participant to earn up to 1.5 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. It is the CE activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Participants who opt-in by providing their ABIM ID and DOB (MM/DD) will earn MOC points equivalent to the amount of CE credits claimed for the activity.

This enduring material is approved for use from March 29, 2023, to July 18, 2024.

How to Participate in This Activity and Obtain CE Credit

• Participants must review all activity information, including the pre-test, learning objectives, faculty disclosure information, simulation scenario(s) and post-activity evaluation.
• To view the first simulation scenario, launch the simulation from the link provided using a PC, Mac, Tablet, or Phone with a 4G or higher internet connection.
• Interact appropriately to satisfy each objective to unlock the next objective and view the next simulation scenario.
• The simulation will track your progress until all scenario objectives are complete.
• Exit the simulation at any time, and your progress will be saved so you can return to finish at a later time.
• As you complete each scenario (1 minimum, 3 total), you will qualify for increasing levels of CE credit (ranging from 0.5 to 1.5 credits). Click or tap "Credit" to determine your CE credit status.
• Upon successful completion of the evaluation, you can download/print a certificate of credit immediately via the browser.

Disclosures

Vindico Medical Education adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a continuing education activity, including faculty, planners, reviewers, or others, are required to disclose all relevant financial relationships with ineligible entities (commercial interests). All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Relationship information is accurate at the time of content development.

Activity Chair and Faculty report the following relevant financial relationship(s)

Scott Kahan, MD, MPH, FTOS, DABOM
Consultant: Gelesis, Lilly, Novo Nordisk, Pfizer, Vivus

Carol H. Wysham, MD, FACP, FACE
Independent Research Contractor: Corcept, Lilly, Novo Nordisk

Planner/Reviewer reports the following relevant financial relationship(s)

Ronald A. Codario, MD, EMBA, FACP, FNLA, RPVI, CHCP
No relevant financial relationships to disclose.

Vindico Medical Education staff report the following relevant financial relationship(s)

No relevant financial relationships to disclose.

Signed disclosures are on file at Vindico Medical Education, Office of Medical Affairs and Compliance.

Unlabeled and Investigational Usage

The audience is advised that this continuing medical education activity may contain references to unlabeled uses of US Food and Drug Administration (FDA)–approved products or to products not approved by the FDA for use in the United States. The faculty members have been made aware of their obligation to disclose such usage. All activity participants will be informed if any speakers/authors intend to discuss either non–FDA-approved or investigational use of products/devices.

Copyright Statement

This CE simulation activity is licensed to Vindico Medical Education. Copyright © 2023 Syandus Inc and Vindico Medical Education. All rights reserved. No part of this simulation activity may be reproduced without written permission from Vindico Medical Education and Syandus Inc.

CE Questions?

Contact us at cme@vindicoCME.com